Kelli Bullard Dunn, MD, FACS, joined the staff of Roswell Park Cancer Institute (RPCI), in 2005, as an attending surgeon to the Gastrointestinal Service in the Department of Surgical Oncology and associate member of the Department of Pharmacology & Therapeutics. She also is an Associate Professor, Department of Surgery at the School of Medicine and Biomedical Sciences at University at Buffalo.

Dr. Bullard Dunn comes to RPCI from the University of Minnesota where she served in the departments of Surgery and Laboratory Medicine and Pathology.  She earned her medical degree at Harvard University, completed residency training at the University of California, San Francisco, and a Fellowship in Colon & Rectal Surgery at the University of Minnesota. She is certified by the American Board of Surgery and the American Board of Colon & Rectal Surgery. She holds a patent for a medical device that holds medical instrumentation.

Dr. Bullard Dunn’s research interests focus on the growth and progression of colorectal carcinoma. Her clinical research involves patterns of recurrence in colorectal cancer and surgical complications of neoadjuvant therapy. Her basic science research investigates cell-matrix interactions in colorectal cancer cells.

Dr. Bullard Dunn is a member of the Society of University Surgeons, American College of Surgeons, Association for Academic Surgery, Association for Surgical Education, American Society of Colon and Rectal Surgeons, American Medical Association and the Association of Women Surgeons. She has authored or co-authored more than 70 journal articles, abstracts and book chapters.